The market report provides current cardiotoxicity treatment practices, emerging drugs, market share of individual therapies, ...

Tempus AI's growth in precision oncology drives an 80% revenue boost by 2025. Click here to find out why I rate TEM stock a ...

Recent developments in the biliary tumor drug landscape have substantially expanded treatment options. In May 2024, AstraZeneca initiated Phase III clinical trials for Rilvegostomig, a promising ...

Here’s how to ID fake weight loss drugs Imagine this scenario: You’ve been diligently working toward your weight management goals, and your healthcare team has prescribed Wegovy (semaglutide).

AstraZeneca plans a $50 billion investment in U.S. facilities by 2030, including a Virginia plant focused on weight loss and metabolic drugs.

AstraZeneca plans to plough billions of pounds into US manufacturing as the drugs giant faces the threat of looming tariffs.

British pharmaceuticals giant AstraZeneca has revealed it plans to invest $50 billion (£37 billion) in America over the next five years. The commitment came only a week ahead of expected ...

British pharmaceuticals giant AstraZeneca has revealed it plans to invest $50 billion (£37 billion) in America over the next five years. The commitment came only a week ahead of expected confirmation ...